カテゴリ： Bizwit Research & Consulting, 世界, 医療/バイオ

網膜障害治療の世界市場：疾患徴候別（黄斑変性、糖尿病性網膜症、糖尿病黄斑浮腫、その他（網膜静脈閉塞など））、治療クラス別（抗VEGF剤、その他（抗炎症薬など））、投与形態別（ゲル、目薬、カプセル＆錠剤、点眼薬、軟膏）、流通経路別（病院薬局、小売薬局、オンライン販売）

◆英語タイトル：Global Retinal Disorder Treatment Market Size study, by Disease Indication (Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, Others (Retinal Vein Occlusion, etc.)), by Therapeutic Class (Anti-VEGF Agents, Others (Anti-inflammatory Drugs, etc.)), by Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales) and Regional Forecasts 2019-2026
◆商品コード：BZW20FB159
◆発行会社（リサーチ会社）：Bizwit Research & Consulting
◆発行日：2020年1月21日
◆ページ数：約200
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥524,700見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥662,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、網膜障害治療の世界市場について調べ、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、疾患徴候別（黄斑変性、糖尿病性網膜症、糖尿病黄斑浮腫、その他（網膜静脈閉塞など））分析、治療クラス別（抗VEGF剤、その他（抗炎症薬など））分析、投与形態別（ゲル、目薬、カプセル＆錠剤、点眼薬、軟膏）分析、流通経路別（病院薬局、小売薬局、オンライン販売）分析、地域別分析、競争状況などで構成されています。
・エグゼクティブサマリー
・市場の定義・範囲
・市場動向
・産業分析
・網膜障害治療の世界市場：疾患徴候別（黄斑変性、糖尿病性網膜症、糖尿病黄斑浮腫、その他（網膜静脈閉塞など））
・網膜障害治療の世界市場：治療クラス別（抗VEGF剤、その他（抗炎症薬など））
・網膜障害治療の世界市場：投与形態別（ゲル、目薬、カプセル＆錠剤、点眼薬、軟膏）
・網膜障害治療の世界市場：流通経路別（病院薬局、小売薬局、オンライン販売）
・網膜障害治療の世界市場：地域別
・競争状況
【レポートの概要】

Global Retinal Disorder Treatment Market is valued approximately at USD 8.73 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.10% over the forecast period 2019-2026. Retina is a thin membranous lining at the back of the eye. It is a light sensitive nerve tissue on which the images focused and converted into electrical impulses which are carried to the brain via optic nerve. Retinal disorders affect the important tissues of the eye and can even cause temporary to permanent blindness. According to World Health Organization 2019, over 295 million people are visually impaired worldwide of which 39 million are blind. Further, retinal diseases are the most common cause of childhood blindness across the globe. Some of these children are blinded by inherited retinal diseases (IRD) like retinitis pigmentosa (incurable) while many of them can have retinopathy of prematurity (curable). Growing retinal diseases worldwide calls for the need of affordable and effective treatment alternatives which in turn will drive the global retinal disorder treatment market. Also, technical advancements, new product launches, collaborations and other strategies being executed by the major players is anticipated to provide low cost and effective retinal disorder treatment and hence fuel the market growth. Moreover, government and other nonprofit organizations are increasing spending on the treatment of retinal disorder treatments. For instance, The Foundation Fighting Blindness, a nonprofit organization established on 1971, is leading a collaborative effort among scientists, patients, their families and the commercial sector to propel the development of preventions, treatments, and cures for inherited retinal diseases (IRDs). Therefore, rising awareness, collaborative efforts and initiatives by the key players are the factors likely to create growth opportunities to the retinal disorder treatment market over the forecast period.

The regional analysis of global Retinal Disorder Treatment Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of key market players in the region. Also, increasing prevalence of retinal disorders is expected to fuel the regional growth. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising awareness about early diagnosis, high unmet clinical needs and availability of effective treatment methods are responsible for the high CAGR of the region over the forecast period.

Major market player included in this report are:
Santen Pharmaceutical Co., Ltd.
Regeneron Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Allergan plc
Shire (Takeda Pharmaceutical Company Limited)
Bayer AG
Graybug Vision, Inc.
Novartis AG
Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Indication:
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Others (Retinal Vein Occlusion, etc.)

By Therapeutic Class:
Anti-VEGF Agents
Others (Anti-inflammatory Drugs, etc.)

By Dosage Form:
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Sales

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Retinal Disorder Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Retinal Disorder Treatment Market, by Disease Indication, 2017-2026 (USD Billion)
1.2.2. Retinal Disorder Treatment Market, by Therapeutic Class, 2017-2026 (USD Billion)
1.2.3. Retinal Disorder Treatment Market, by Dosage Form, 2017-2026 (USD Billion)
1.2.4. Retinal Disorder Treatment Market, by Distribution Channel, 2017-2026 (USD Billion)
1.2.5. Retinal Disorder Treatment Market, by Region, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Retinal Disorder Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Retinal Disorder Treatment Market Dynamics
3.1. Retinal Disorder Treatment Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Retinal Disorder Treatment Market Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Retinal Disorder Treatment Market, by Disease Indication
5.1. Market Snapshot
5.2. Global Retinal Disorder Treatment Market by Disease Indication, Performance – Potential Analysis
5.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Disease Indication 2016-2026 (USD Billion)
5.4. Retinal Disorder Treatment Market, Sub Segment Analysis
5.4.1. Macular Degeneration
5.4.2. Diabetic Retinopathy
5.4.3. Diabetic Macular Edema
5.4.4. Others (Retinal Vein Occlusion, etc.)
Chapter 6. Global Retinal Disorder Treatment Market, by Therapeutic Class
6.1. Market Snapshot
6.2. Global Retinal Disorder Treatment Market by Therapeutic Class, Performance – Potential Analysis
6.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Therapeutic Class, 2016-2026 (USD Billion)
6.4. Retinal Disorder Treatment Market, Sub Segment Analysis
6.4.1. Anti-VEGF Agents
6.4.2. Others (Anti-inflammatory Drugs, etc.)
Chapter 7. Global Retinal Disorder Treatment Market, by Dosage Form
7.1. Market Snapshot
7.2. Global Retinal Disorder Treatment Market by Dosage Form, Performance – Potential Analysis
7.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Dosage Form, 2016-2026 (USD Billion)
7.4. Retinal Disorder Treatment Market, Sub Segment Analysis
7.4.1. Gels
7.4.2. Eye Solutions
7.4.3. Capsules & Tablets
7.4.4. Eye Drops
7.4.5. Ointments
Chapter 8. Global Retinal Disorder Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Retinal Disorder Treatment Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Distribution Channel, 2016-2026 (USD Billion)
8.4. Retinal Disorder Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Sales
Chapter 9. Global Retinal Disorder Treatment Market, Regional Analysis
9.1. Retinal Disorder Treatment Market, Regional Market Snapshot
9.2. North America Retinal Disorder Treatment Market
9.2.1. U.S. Retinal Disorder Treatment Market
9.2.1.1. Disease Indication breakdown estimates & forecasts, 2016-2026
9.2.1.2. Therapeutic Class breakdown estimates & forecasts, 2016-2026
9.2.1.3. Dosage Form breakdown estimates & forecasts, 2016-2026
9.2.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Retinal Disorder Treatment Market
9.3. Europe Retinal Disorder Treatment Market Snapshot
9.3.1. U.K. Retinal Disorder Treatment Market
9.3.2. Germany Retinal Disorder Treatment Market
9.3.3. Rest of Europe Retinal Disorder Treatment Market
9.4. Asia-Pacific Retinal Disorder Treatment Market Snapshot
9.4.1. China Retinal Disorder Treatment Market
9.4.2. India Retinal Disorder Treatment Market
9.4.3. Japan Retinal Disorder Treatment Market
9.4.4. Rest of Asia Pacific Retinal Disorder Treatment Market
9.5. Latin America Retinal Disorder Treatment Market Snapshot
9.5.1. Brazil Retinal Disorder Treatment Market
9.5.2. Mexico Retinal Disorder Treatment Market
9.6. Rest of The World Retinal Disorder Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Santen Pharmaceutical Co., Ltd.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject To Data Availability)
10.2.1.4. Sensor Type Summary
10.2.1.5. Recent Developments
10.2.2. Regeneron Pharmaceuticals, Inc.
10.2.3. F. Hoffmann-La Roche Ltd.
10.2.4. Pfizer, Inc.
10.2.5. Allergan plc
10.2.6. Shire (Takeda Pharmaceutical Company Limited)
10.2.7. Bayer AG
10.2.8. Graybug Vision, Inc.
10.2.9. Novartis AG
10.2.10. Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY EQUIPMENT TYPES, USED IN THE STUDY OF GLOBAL RETINAL DISORDER TREATMENT MARKET
TABLE 2. LIST OF PRIMARY EQUIPMENT TYPES, USED IN THE STUDY OF GLOBAL RETINAL DISORDER TREATMENT MARKET
TABLE 3. GLOBAL RETINAL DISORDER TREATMENT MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DISEASE INDICATION 2016-2026 (USD BILLION)
TABLE 8. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY THERAPEUTIC CLASS 2016-2026 (USD BILLION)
TABLE 9. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DOSAGE FORM 2016-2026 (USD BILLION)
TABLE 10. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2016-2026 (USD BILLION)
TABLE 11. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 59. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 61. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 62. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[網膜障害治療の世界市場：疾患徴候別（黄斑変性、糖尿病性網膜症、糖尿病黄斑浮腫、その他（網膜静脈閉塞など））、治療クラス別（抗VEGF剤、その他（抗炎症薬など））、投与形態別（ゲル、目薬、カプセル＆錠剤、点眼薬、軟膏）、流通経路別（病院薬局、小売薬局、オンライン販売）]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 降圧薬の世界市場：治療クラス別（利尿薬、ACE阻害薬、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他）、流通経路別（小売薬局、病院薬局、Eコマース、その他）
    AMR20FE071 / Allied Market Research / 2019年12月31日 / 本調査レポートでは、降圧薬の世界市場について調べ、イントロダクション、エグゼクティブサマリー、市場概要、治療クラス別（利尿薬、ACE阻害薬、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他）分析、流通経路別（小売薬局、病院薬局、Eコマース、その他）分析、地域別分析、企業概要などを総合的、多面的にまとめております。 ・イントロダクション ・エグゼクティブサマリ－ ・市場概要 ・降圧薬の世界市場：治療クラス別（利尿薬、ACE阻害薬、カルシウムチャネル遮断薬、血管拡張薬、ベータアドレナリン遮断薬、その他） ・降圧薬の世界市場：流通経路別（小売薬局、病院薬局、Eコマース、その他） ・降圧薬の世界市場：地域別 ・企業概要...The global antihypertensive market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2026, registering a CAGR of 3.1% from 2019 to 2026. Antihypertensive drugs are employed for the treatment of patients suffering from hypertension. Hypertension is a medical condition, which involves rise in blood pressure in the arteries. Furthermore, the patient suffering from hypertension is highly susceptible to other complications, which include heart failure and aneurysm. Therefore, the treatment of this medical condition requires early diagnosis and management by the use of antihypertensive drugs. Some of the antihypertensive drugs available in the market include...
  2. ヒト成長ホルモン（hGH）の世界市場：用途別（成長ホルモン欠乏症、プラダー・ウィリー症候群、ターナー症候群、在胎不当過小、その他）、投与経路別（静脈内、筋肉内、皮下、経口）、流通経路別（病院薬局、小売薬局、クリニック、 オンライン薬局）
    AMR20JN012 / Allied Market Research / 2019年11月13日 / 本市場調査レポートではヒト成長ホルモン（hGH）について、イントロダクション、エグゼクティブサマリー、市場概要、用途別（成長ホルモン欠乏症、プラダー・ウィリー症候群、ターナー症候群、在胎不当過小、その他）分析、投与経路別（静脈内、筋肉内、皮下、経口）分析、流通経路別（病院薬局、小売薬局、クリニック、 オンライン薬局）分析、地域別分析、企業概要に区分して収録しています。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・ヒト成長ホルモン（hGH）の世界市場：用途別（成長ホルモン欠乏症、プラダー・ウィリー症候群、ターナー症候群、在胎不当過小、その他） ・ヒト成長ホルモン（hGH）の世界市場：投与経路別（静脈内、筋肉内、皮下、経口） ・ヒト成長ホルモン（hGH）の世界市場：流通経路別（病院薬局、小売薬局、クリニック、 オンライン薬局） ・ヒト成長ホルモン（hGH）の世界市場：地域別...The global human growth hormone market was valued at $2,840.70 million in 2018 and is expected to reach $5,563.60 million by 2026, registering a CAGR of 8.6% from 2019 to 2026. Human growth hormone is a protein made by the pituitary gland and is secreted into the bloodstream to other parts of the body. Its production is regulated by an intricate set of hormones produced in the hypothalamus gland, intestinal tract, and pancreas. Further, these hormones act on several tissues throughout the body. In adolescents, it stimulates the growth of bone and cartilage. Whereas in adults, it boosts protein production,...
  3. ヘルスケア流通サービスの世界市場：タイプ別（医薬品流通サービス、医療機器流通サービス、バイオ医薬品流通サービス）、エンドユーザー別（小売薬局、病院薬局、その他のエンドユーザー）、地域別予測
    BZW9OT033 / Bizwit Research & Consulting / 2019年9月 / 本資料は、ヘルスケア流通サービスの世界市場について調べ、ヘルスケア流通サービスの世界規模、市場動向、市場環境、タイプ別（医薬品流通サービス、医療機器流通サービス、バイオ医薬品流通サービス）分析、エンドユーザー別（小売薬局、病院薬局、その他のエンドユーザー）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・ヘルスケア流通サービスの世界市場概要 ・ヘルスケア流通サービスの世界市場環境 ・ヘルスケア流通サービスの世界市場動向 ・ヘルスケア流通サービスの世界市場規模 ・ヘルスケア流通サービスの世界市場規模：タイプ別（医薬品流通サービス、医療機器流通サービス、バイオ医薬品流通サービス） ・ヘルスケア流通サービスの世界市場規模：エンドユーザー別（小売薬局、病院薬局、その他のエンドユーザー） ・ヘルスケア流通サービスの世界市場：地域別市場規模・分析...Global Healthcare Distribution Services Market is valued approximately USD 718.50 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.50 % over the forecast period 2019-2026. Healthcare distribution Services market includes moving and storing pharmaceutical goods from plants to wholesalers, hospitals and patients. Also, the healthcare companies must comply with stringent public regulation as pharmaceutical products should be available in useable shapes to ensure their safety records. Further, high incidences of chronic diseases and increasing uptake of biopharmaceuticals has led the adoption of healthcare distribution services across the forecast period. As per the...
  4. 口腔ケアの世界市場：製品別（歯磨き粉、歯ブラシ・付属品、マウスウォッシュ・リンス、歯科関連製品、義歯関連製品、義歯用洗浄液）、販売チャネル別（小売店、小売薬局、オンライン販売、歯科医院内薬局）、地域別予測
    BZW8100427 / Bizwit Research & Consulting / 2018年9月24日 / 本資料は、口腔ケアの世界市場について調べ、口腔ケアの世界規模、市場動向、市場環境、製品別（歯磨き粉、歯ブラシ・付属品、マウスウォッシュ・リンス、歯科関連製品、義歯関連製品、義歯用洗浄液）分析、販売チャネル別（小売店、小売薬局、オンライン販売、歯科医院内薬局）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはColgate-Palmolive Company、The Procter & Gamble Company 、Glaxosmithkline PLC 、Unilever PLC...Global Oral Care Market to reach USD 64.1 billion by 2025. Global Oral Care Market valued approximately USD 43.7 billion in 2017 is anticipated to grow with a healthy growth rate of more than 4.9% over the forecast period 2018-2025. High dental caries incidences, rapidly increasing geriatric population across the globe, recent developments in the medical science technology and innovative products in the dental and oral care field are the major factors driving the growth of the Global Oral Care Market. Furthermore, the availability of different oral care products like gels, pastes, and powder as toothpaste, deep clean, daily clean,...
  5. 糖尿病性神経障害の世界市場：疾患の種類別（自律神経障害、末梢神経障害、近位筋優位遺伝性運動感覚ニューロパチー、限局性神経障害）、治療別（薬物、理学療法、放射線療法、その他）、流通経路別（診療所、病院、薬局）、地域別予測
    BZW9MR024 / Bizwit Research & Consulting / 2019年3月7日 / 本資料は、糖尿病性神経障害の世界市場について調べ、糖尿病性神経障害の世界規模、市場動向、市場環境、疾患の種類別（自律神経障害、末梢神経障害、近位筋優位遺伝性運動感覚ニューロパチー、限局性神経障害）分析、治療別（薬物、理学療法、放射線療法、その他）分析、流通経路別（診療所、病院、薬局）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはPfizer Inc.、 Janssen Pharmaceuticals, Inc.、 Eli Lilly and Company、 Cephalon,...Global diabetic neuropathy market to reach USD 5.8 billion by 2025. Global diabetic neuropathy market is valued approximately USD 3.8 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 5.4 % over the forecast period 2018-2025. Key trends in the market is advent of new therapeutics for treatment of neuropathy and favorable reimbursement scenario which is expected to foster the growth of the diabetic neuropathy market. For instance: In 2016 as per the University of Cambridge, researchers have led to the development of a new approach to treatment of neuropathic pain. Further, the...
  6. リウマチ科治療法の世界市場：疾病種類別（慢性関節リウマチ、強直性脊椎炎、変形性関節症、ループス、痛風、その他）、薬種類別（非ステロイド性抗炎症薬（NSAID）、鎮痛剤、疾患修飾性抗リウマチ薬（DMARD）、副腎皮質ステロイド、その他）、流通チャネル別（小売薬局、オンライン薬局、病院、その他）、地域別予測
    BZW9JN110 / Bizwit Research & Consulting / 2019年6月25日 / 本資料は、リウマチ科治療法の世界市場について調べ、リウマチ科治療法の世界規模、市場動向、市場環境、疾病種類別（慢性関節リウマチ、強直性脊椎炎、変形性関節症、ループス、痛風、その他）分析、薬種類別（非ステロイド性抗炎症薬（NSAID）、鎮痛剤、疾患修飾性抗リウマチ薬（DMARD）、副腎皮質ステロイド、その他）分析、流通チャネル別（小売薬局、オンライン薬局、病院、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・リウマチ科治療法の世界市場概要 ・リウマチ科治療法の世界市場環境 ・リウマチ科治療法の世界市場動向 ・リウマチ科治療法の世界市場規模 ・リウマチ科治療法の世界市場規模：疾病種類別（慢性関節リウマチ、強直性脊椎炎、変形性関節症、ループス、痛風、その他） ・リウマチ科治療法の世界市場規模：薬種類別（非ステロイド性抗炎症薬（NSAID）、鎮痛剤、疾患修飾性抗リウマチ薬（DMARD）、副腎皮質ステロイド、その他） ・リウマチ科治療法の世界市場規模：流通チャネル別（小売薬局、オンライン薬局、病院、その他）...Global Rheumatology Therapeutics Market valued approximately USD 44.38 billion in 2018 is anticipated to grow with a healthy growth rate of more than 2.73% over the forecast period 2019-2026. The Rheumatology Therapeutics Market is continuously growing in the global scenario at significant pace. Rheumatology therapeutics market consists of therapeutics used for the treatment of rheumatic disorders, which include rheumatoid arthritis, juvenile rheumatoid arthritis, spondylarthritis, systemic lupus erythematosus, and systemic sclerosis. It is also associated with pain disorders in joints, ligaments and muscles. Rising incidence of rheumatology diseases, rising geriatric population worldwide are the substantial driving factors of the market during...
  7. 植物および植物由来の薬物の世界市場：ソース別（植物、藻類、肉眼的真菌）、剤形別（丸薬、錠剤、カプセル、注射）、治療用途別（中枢神経系、心血管疾患、感染症、呼吸器疾患）
    BZW20JN014 / Bizwit Research & Consulting / 2019年12月31日 / 本調査レポートでは植物および植物由来の薬物について、エグゼクティブサマリー、定義および範囲、市場動向、産業分析、ソース別（植物、藻類、肉眼的真菌）分析、剤形別（丸薬、錠剤、カプセル、注射）分析、治療用途別（中枢神経系、心血管疾患、感染症、呼吸器疾患）分析、地域別分析、競争状況、調査プロセスなどを総合的、多面的に調査・分析しました。 ・エグゼクティブサマリー ・定義および範囲 ・市場動向 ・産業分析 ・植物および植物由来の薬物の世界市場：ソース別（植物、藻類、肉眼的真菌） ・植物および植物由来の薬物の世界市場：剤形別（丸薬、錠剤、カプセル、注射） ・植物および植物由来の薬物の世界市場：治療用途別（中枢神経系、心血管疾患、感染症、呼吸器疾患） ・植物および植物由来の薬物の世界市場：地域別 ・競争状況...Global Botanical and plant-derived drugs market is valued approximately at USD 31.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.10% over the forecast period 2019-2026. Botanical drugs are derived from medicinal plants. Botanical drugs contain algae vegetable substance, and macroscopic fungi. Botanical and plant derived drugs help in treatment of various diseases, such as central nervous system disorders, infectious diseases cardiovascular diseases, and respiratory diseases. These drugs are used as an important component in medicine and therapies such as homeopathy and ayurvedic medicines. Increasing risk of side effects with the consumption...
  8. コンタクトレンズの世界市場：材料別（ガス透過性、シリコーンハイドロゲル）、デザイン別、用途別、流通経路別、地域別、セグメント予測
    GV9DE011 / Grand View Research / 2019年11月14日 / 本レポートでは、コンタクトレンズの世界市場について調査手法および範囲、エグゼクティブサマリ－、変数・傾向、材料別（ガス透過性、シリコーンハイドロゲル）分析、デザイン別（球面レンズ、トーリックレンズ、多焦点レンズ、その他）分析、用途別（矯正、治療、コスメ、補綴、ライフスタイル）分析、流通経路別（Eコマース、小売）分析、地域別分析、競合状況などを総合的、多面的に調査・分析しました。 ・調査手法および範囲 ・エグゼクティブサマリ－ ・コンタクトレンズ市場：変数・傾向 ・コンタクトレンズの世界市場：材料別（ガス透過性、シリコーンハイドロゲル） ・コンタクトレンズの世界市場：デザイン別（球面レンズ、トーリックレンズ、多焦点レンズ、その他） ・コンタクトレンズの世界市場：用途別（矯正、治療、コスメ、補綴、ライフスタイル） ・コンタクトレンズの世界市場：流通経路別（Eコマース、小売） ・コンタクトレンズの世界市場：地域別分析 ・競合状況...The global contact lenses market size is expected to reach USD 17.7 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 5.6% from 2019 to 2025. The use of innovative materials for manufacturing contact lenses and increasing adoption of contact lenses are prominent factors boosting the growth of the market. The rising tendency of youngsters to enhance their aesthetic appearance and growing aging population is expected to drive the market over the forecast period. Also, global factors such as the rising disposable income and improvement in...
  9. 性具の世界市場：タイプ別（女性、男性）、流通経路別（Eコマース、専門店、量販店）、セグメント予測
    GV9DE031 / Grand View Research / 2019年10月3日 / 本レポートでは、性具の世界市場について、調査手法・範囲、エグゼクティブサマリ－、市場変数・傾向、タイプ別（女性、男性）分析、流通経路別（Eコマース、専門店、量販店）分析、地域別分析、競合分析などを総合的、多面的に調査・分析しました。 ・調査手法・範囲 ・エグゼクティブサマリ－ ・市場変数・傾向 ・性具の世界市場：タイプ別（女性、男性） ・性具の世界市場：流通経路別（Eコマース、専門店、量販店） ・性具の世界市場：地域別分析 ・競合状況...The global sex toys market size is expected to reach USD 52.7 billion by 2026, based on a new report by Grand View Research, Inc., exhibiting a CAGR of 9.1%. Use of innovative technology for designing and manufacturing of sex toy is anticipated to augment growth during the forecast period. Users are moving from traditional vibrators and penile rings to devices that can be operated via mobile applications. In April 2017, We-Vibe, a Canadian manufacturer, launched its two-way controlled We-Connect app that was made available free of cost on Apple and Android devices. The company reported 2 million customers are...
  10. リウマチ性関節炎用薬・治療法の世界市場：分子タイプ別（バイオ医薬品、医薬品）、販売ルート別（処方箋、一般用医薬品（OTC））、地域別予測
    BZW9JN109 / Bizwit Research & Consulting / 2019年6月25日 / 本資料は、リウマチ性関節炎用薬・治療法の世界市場について調べ、リウマチ性関節炎用薬・治療法の世界規模、市場動向、市場環境、分子タイプ別（バイオ医薬品、医薬品）分析、販売ルート別（処方箋、一般用医薬品（OTC））分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・リウマチ性関節炎用薬・治療法の世界市場概要 ・リウマチ性関節炎用薬・治療法の世界市場環境 ・リウマチ性関節炎用薬・治療法の世界市場動向 ・リウマチ性関節炎用薬・治療法の世界市場規模 ・リウマチ性関節炎用薬・治療法の世界市場規模：分子タイプ別（バイオ医薬品、医薬品） ・リウマチ性関節炎用薬・治療法の世界市場規模：販売ルート別（処方箋、一般用医薬品（OTC）） ・リウマチ性関節炎用薬・治療法の世界市場：地域別市場規模・分析...Global Rheumatoid Arthritis Drugs/Therapeutics Market valued approximately USD 22.14 billion in 2018 is anticipated to grow with a healthy growth rate of more than 4.50% over the forecast period 2019-2026. The Rheumatoid Arthritis Drugs/Therapeutics Market is continuously growing in the global scenario at significant pace. Rheumatoid arthritis (RA) is the most common type of autoimmune chronic disease that causes joint pain, swelling and stiffness in joint and even loss of joint function. To overcome this diseases various medications are introduced such as disease-modifying anti-rheumatic drugs (DMARDs), biological response modifiers (a type of DMARD), glucocorticoids, analgesics (painkillers) and nonsteroidal anti-inflammatory medications...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆